🌅 Today's Morning Call
|
S&P Futures
7,498.75
▲ +1.25 (+0.02%)
|
Nasdaq Futures
28,550.50
▲ +88.75 (+0.31%)
|
Dow Futures
52,661.00
▲ +86.00 (+0.16%)
|
|
10Y Treasury
4.66%
▲ +0.04%
|
US Dollar
100.34
▲ +0.15 (+0.15%)
|
Bitcoin
$63,680
▼ -$1,042 (-1.61%)
|
👀 What to Watch Today
Today wraps up July trading, which means portfolio managers and funds will be making end-of-month positioning moves. That alone can create unusual volume and price swings in the final hour of trading, so keep that in mind as the session winds down this afternoon.On the macro side, the 10-year Treasury yield is sitting at 4.66% and the 30-year has pushed to 5.21%, both ticking higher overnight. Rising yields tend to put pressure on rate-sensitive sectors like real estate and utilities, so watch those groups if yields keep climbing through the session.
The Dollar Index at 100.34 is also worth monitoring. A firming dollar creates headwinds for multinational earnings and commodities. Bitcoin sliding 1.61% to $63,680 suggests some risk-off flavor in the crypto corner, even as equities futures hold steady.
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🌏 Overnight Recap
The big overnight story out of Europe is Novo Nordisk (NVO), which saw its shares crater roughly 9% after a heart drug candidate failed in clinical trials. That is a brutal result for a company that has been riding high on its GLP-1 weight loss franchise. The failure serves as a reminder that drug development pipelines carry real binary risk, and NVO shareholders are feeling that this morning.Also in the pharmaceutical space, Moderna (MRNA) beat earnings expectations but the stock is falling anyway. The company continues to lean heavily on Covid vaccine revenue, and the market is clearly not satisfied with that dependency. Beats mean little when investors are skeptical about the growth story underneath the headline numbers.
Over in Asia and Europe, Sun Pharmaceutical Industries posted a 27% jump in quarterly profit, driven by strong demand for high-margin specialty medicines. That is a bright spot in what is otherwise a rough morning for the broader pharma sector.
The SpaceX IPO Wasn't For You
📊 Pre-Market Movers
Novo Nordisk (NVO) is the headline mover this morning, shedding around 9% in pre-market trading after its experimental heart drug washed out in a clinical trial. The stock had already been navigating a complicated stretch as competition in the weight loss drug space intensifies. This setback removes a key pipeline catalyst that investors had been counting on.Moderna (MRNA) is also in the red despite posting an earnings beat. Revenue continues to be dominated by Covid vaccine sales, and the market has heard that story enough times to know it comes with a shelf life. The stock's negative reaction to a beat is the market asking a simple question: what comes next?
On the deal side, Alimentation Couche-Tard (ANCTF) is drawing attention after announcing an $8.7 billion plan to acquire Polish convenience chain Zabka. It is a bold international move for the Canadian retailer and one that could reshape how investors think about the company's growth runway outside North America.
🔍 Today's Watchlist
- NVO: Down roughly 9% pre-market after a heart drug trial failure. Watch whether the sell-off stabilizes or deepens at the open.
- MRNA: Beat earnings but falling anyway. The Covid revenue dependency narrative is not going away, and today's reaction will tell you how patient investors are.
- ANCTF: Couche-Tard is swinging big with an $8.7 billion bid for Poland's Zabka. Watch for analyst reactions to this international expansion move.
- Treasury yields: The 10-year at 4.66% and 30-year at 5.21% are both creeping higher. Any acceleration there could put a ceiling on today's futures optimism.
- SHEL: Shell is offloading BG Cyprus for up to $720 million. A smaller deal, but it signals continued portfolio pruning from Big Oil as the energy transition reshapes capital priorities.
Trump Is Replacing The U.S. Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.
🎯 The Morning Playbook
The setup for Friday is a tale of two stories. Futures are green, but the sector-level damage in pharma is real and could drag on the broader healthcare index early in the session. If you hold NVO or MRNA, today is about managing position size rather than chasing a bounce on emotion.For everyone else, the end-of-month dynamic is the meta story. Expect some choppy, repositioning-driven action in the afternoon as funds square up for July. The macro backdrop, rising yields and a slightly firmer dollar, is not screaming bull market, but it is not a red flag either.
Finish the month with a clear head. The news flow today is manageable and the catalysts are well-defined. Sometimes the best trade on a Friday like this is simply staying disciplined and knowing what you own.
📰 Further Reading
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known comp...
Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
This tiny $2 stock holds the exclusive rights to the largest gold reserve in the country. And it has the potential to be the biggest fortune maker in Trump’s second term. According to Jim Rickards... Trump is about to take a direct stake in this $2 stock. And if you’d like to learn how to stake your...
Click here to see Jim’s big prediction: “Trump’s Next Big Buy.”
I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concerns me. With the national debt hitting $38 trillion and growing $8 billion daily, this intelligence report is more critical than ever. But we may have to take it down soon.
Download The Big Beautiful Bubble Report FREE